Enhanced efficiency in cell killing at the penetration depths around the Bragg peak of a radioactive 9C-ion beam

Conclusion: The potential advantage of radioactive 9C-ion beam in cancer therapy has been revealed at low dose rate in comparison with a therapeutic 12C beam. This observation, however, remains to be investigated at therapeutic dose rates in the future.